메뉴 건너뛰기




Volumn 91, Issue 6 SUPPL. 1, 2003, Pages 9-14

Improving clinical outcomes with drug treatment in heart failure: What have trials taught?

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CYTOKINE RECEPTOR ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; NEUROHORMONE; UNCLASSIFIED DRUG; VASOPEPTIDASE INHIBITOR; VASOPRESSIN RECEPTOR ANTAGONIST;

EID: 0037456894     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03374-X     Document Type: Review
Times cited : (27)

References (20)
  • 1
    • 0025153828 scopus 로고
    • Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)
    • Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas J., Liang C.S., Kubo S.H., Rudin-Toretsky E., Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure a substudy of the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation. 82:1990;1724-1729.
    • (1990) Circulation , vol.82 , pp. 1724-1729
    • Francis, G.S.1    Benedict, C.2    Johnstone, D.E.3    Kirlin, P.C.4    Nicklas, J.5    Liang, C.S.6    Kubo, S.H.7    Rudin-Toretsky, E.8    Yusuf, S.9
  • 3
    • 0026704692 scopus 로고
    • Effects of the angiotensin-converting enzyme inhibitor, enalapril, on the long-term progression of left ventricular dysfunction in patients with heart failure
    • Konstam M.A., Rousseau M.F., Kronenberg M.W., Udelson J.E., Melin J., Stewart D., Dolan N., Edens T.R., Ahn S., Kinan D., et al. Effects of the angiotensin-converting enzyme inhibitor, enalapril, on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation. 86:1992;431-438.
    • (1992) Circulation , vol.86 , pp. 431-438
    • Konstam, M.A.1    Rousseau, M.F.2    Kronenberg, M.W.3    Udelson, J.E.4    Melin, J.5    Stewart, D.6    Dolan, N.7    Edens, T.R.8    Ahn, S.9    Kinan, D.10
  • 4
    • 0034609521 scopus 로고    scopus 로고
    • Progress in heart failure management? Lessons from the real world
    • Konstam M.A. Progress in heart failure management? Lessons from the real world. Circulation. 102:2000;1076-1078.
    • (2000) Circulation , vol.102 , pp. 1076-1078
    • Konstam, M.A.1
  • 5
    • 0023266532 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
    • Effects of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 316:1987;1429-1435.
    • (1987) N Engl J Med , vol.316 , pp. 1429-1435
  • 6
    • 0025913812 scopus 로고
    • Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
    • Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
    • (1991) N Engl J Med , vol.325 , pp. 293-302
  • 7
    • 0026785561 scopus 로고
    • Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
    • Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
    • (1992) N Engl J Med , vol.327 , pp. 685-691
  • 9
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
    • Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342:2000;145-153.
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3    Bosch, J.4    Davies, R.5    Dagenais, G.6
  • 10
    • 0030902115 scopus 로고    scopus 로고
    • Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan In The Elderly study, ELITE)
    • Pitt B., Segal R., Martinez F.A., Meurers G., Cowley A.J., Thomas I., Deedwania P.C., Ney D.E., Snavely D.B., Chang P.I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan In The Elderly study, ELITE). Lancet. 349:1997;747-752.
    • (1997) Lancet , vol.349 , pp. 747-752
    • Pitt, B.1    Segal, R.2    Martinez, F.A.3    Meurers, G.4    Cowley, A.J.5    Thomas, I.6    Deedwania, P.C.7    Ney, D.E.8    Snavely, D.B.9    Chang, P.I.10
  • 11
    • 0035818884 scopus 로고    scopus 로고
    • A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    • Cohn J.N., Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 345:2001;1667-1675.
    • (2001) N Engl J Med , vol.345 , pp. 1667-1675
    • Cohn, J.N.1    Tognoni, G.2
  • 12
    • 0032834737 scopus 로고    scopus 로고
    • Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM): Rationale and design. CHARM Programme Investigators
    • Swedberg K., Pfeffer M., Granger C., Held P., McMurray J., Ohlin G., Olofsson B., Ostergren J., Yusuf S. Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM): rationale and design. CHARM Programme Investigators. J Card Fail. 5:1999;276-282.
    • (1999) J Card Fail , vol.5 , pp. 276-282
    • Swedberg, K.1    Pfeffer, M.2    Granger, C.3    Held, P.4    McMurray, J.5    Ohlin, G.6    Olofsson, B.7    Ostergren, J.8    Yusuf, S.9
  • 15
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomised trial. Lancet. 353:1999;9-13.
    • (1999) Lancet , vol.353 , pp. 9-13
  • 16
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    • Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 353:1999;2001-2007.
    • (1999) Lancet , vol.353 , pp. 2001-2007
  • 18
    • 0031051347 scopus 로고    scopus 로고
    • The effect of digoxin on mortality and morbidity in patients with heart failure
    • The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 336:1997;525-533.
    • (1997) N Engl J Med , vol.336 , pp. 525-533
  • 19
    • 0037143601 scopus 로고    scopus 로고
    • Comparison of omapatrilat and enalapril in patients with chronic heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)
    • Packer M., Califf R.M., Konstam M.A., Krum H., McMurray J.J., Rouleau J.L., Swedberg K. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE). Circulation. 106:2002;R21-R27.
    • (2002) Circulation , vol.106
    • Packer, M.1    Califf, R.M.2    Konstam, M.A.3    Krum, H.4    McMurray, J.J.5    Rouleau, J.L.6    Swedberg, K.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.